医疗机器人市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球医疗机器人市场规模将达到 128 亿美元，预计 2025 年至 2034 年期间复合年增长率将达到 16.6%。 这一显着增长得益于医疗保健领域自动化程度的不断提高、政府和私人组织的大量投资以及微创手术的日益普及。由于医疗保健产业面临巨大的压力，需要应对成本不断上涨、劳动力短缺和精准度要求等挑战，医疗机器人已成为改变游戏规则的解决方案。这些先进的系统不仅优化了资源利用率，而且还提高了程序的准确性，减少了错误并改善了患者的治疗效果。它们的应用范围从复杂的手术到復健和病人监测，使它们在整个医疗保健环境中不可或缺。人工智慧机器人和 3D 成像等技术进步进一步推动了市场发展，彻底改变了医疗保健提供者提供护理的方式。

医疗机器人正在透过解决关键的效率低下问题并提供可靠、经济高效的解决方案来改变医疗保健。这些系统能够提高手术精度、一致性復健护理和即时患者监测，从而改善临床结果并提高患者满意度。它们在减少人为错误、简化操作和自主完成任务方面特别有效。机器人技术的日益普及反映了医疗保健产业致力于利用创新来提供更好的医疗服务。随着医院和诊所寻求提高效率和病患体验，全球对医疗机器人的需求正在激增。

市场分为几个主要部分，包括远距医疗机器人、药房和医院自动化机器人、手术机器人、復健机器人和非侵入性放射外科机器人。其中，手术机器人在2024年占据市场主导地位，创造了81亿美元的收入。它们能够提供更安全、更有效的结果，这使得它们在微创手术中成为不可或缺的一部分。这些机器人以其无与伦比的精度、减少的失血量和更快的恢復时间而闻名，在世界各地的手术室中得到广泛应用。

医疗机器人的应用涉及多个领域，包括腹腔镜手术、骨科手术、神经病学、心臟病学、药房运作和物理復健。腹腔镜系统在 2024 年引领市场，贡献 43 亿美元的收入。人工智慧引导、3D 成像和即时分析等技术创新使外科医生能够以最小的组织损伤执行复杂的手术，从而推动了对这些系统的需求增加。

2024年北美医疗机器人市场价值为78亿美元，占全球市场的很大份额。该地区的主导地位归因于高医疗支出、支持性政策以及对机器人技术的更高认知。肥胖症和心血管疾病等慢性病的流行加剧了对机器人辅助手术（尤其是腹腔镜手术）的需求。这一趋势促使该地区的医疗机构大力投资机器人系统，进一步推动市场成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 机器人辅助手术的广泛健康保险计划
    • 外科手术数量增加
    • 手术机器人的普及率很高
    • 技术进步
  • 产业陷阱与挑战
    • 机器人系统成本高
    • 缺乏意识
    • 严格的监管审批
• 成长潜力分析
• 监管格局
  • 我们
  • 欧洲
• 技术格局
• 未来市场趋势
• 差距分析
• 价值链分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按产品类型，2021 年至 2034 年

• 主要趋势
• 手术机器人
• 药局和医院自动化机器人
• 復健机器人
• 远距医疗机器人
• 非侵入性放射外科机器人

第 6 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 腹腔镜
• 骨科
• 神经病学
• 心臟病学
• 药房应用
• 物理復健
• 其他应用

第 7 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 门诊手术中心 (ASC)
• 復健中心
• 其他最终用途

第 8 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• ACCURAY
• Aethon
• ARxIUM
• Capsa Healthcare
• Globus Medical
• Hocoma
• Intuitive Surgical
• Johnson & Johnson
• Medtronic
• Omnicell
• Reinshaw
• Smith & Nephew
• Stryker Corporation
• THINK Surgical
• Zimmer Biomet

The Global Medical Robots Market reached USD 12.8 billion in 2024 and is projected to expand at a robust CAGR of 16.6% from 2025 to 2034. This remarkable growth is fueled by the increasing integration of automation in healthcare, significant investments from governments and private organizations, and the rising popularity of minimally invasive procedures. With the healthcare sector under immense pressure to address challenges like escalating costs, workforce shortages, and the demand for precision, medical robots have emerged as a game-changing solution. These advanced systems not only optimize resource utilization but also enhance procedural accuracy, reduce errors, and improve patient outcomes. Their applications range from complex surgeries to rehabilitation and patient monitoring, making them indispensable across healthcare settings. The market is further driven by technological advancements, such as AI-powered robotics and 3D imaging, revolutionizing how healthcare providers deliver care.

Medical robots are transforming healthcare by addressing critical inefficiencies and offering reliable, cost-effective solutions. These systems enable enhanced surgical precision, consistent rehabilitation care, and real-time patient monitoring, leading to improved clinical outcomes and higher patient satisfaction. They are particularly effective in reducing human errors, streamlining operations, and delivering tasks autonomously. The growing adoption of robotic technologies reflects the healthcare industry's commitment to leveraging innovation for better care delivery. As hospitals and clinics seek to improve efficiency and patient experience, the demand for medical robots is surging globally.

The market is categorized into key segments, including telemedicine robots, pharmacy and hospital automation robots, surgical robots, rehabilitation robots, and non-invasive radiosurgery robots. Among these, surgical robots dominated the market in 2024, generating USD 8.1 billion in revenue. Their ability to deliver safer and more efficient outcomes has made them indispensable in minimally invasive procedures. These robots are recognized for their unmatched precision, reduced blood loss, and faster recovery times, leading to their widespread adoption in operating rooms worldwide.

Applications of medical robots span diverse domains, including laparoscopic surgeries, orthopedic procedures, neurology, cardiology, pharmacy operations, and physical rehabilitation. Laparoscopic systems led the market in 2024, contributing USD 4.3 billion in revenue. Technological innovations like AI-driven guidance, 3D imaging, and real-time analytics empower surgeons to perform complex procedures with minimal tissue damage, driving increased demand for these systems.

North America medical robots market generated USD 7.8 billion in 2024, accounting for a substantial share of the global market. The region's dominance is attributed to high healthcare spending, supportive policies, and greater awareness of robotic technologies. The prevalence of chronic conditions, such as obesity and cardiovascular diseases, has heightened the need for robotic-assisted surgeries, particularly laparoscopic procedures. This trend has prompted healthcare facilities across the region to invest heavily in robotic systems, further fueling market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Broad health coverage plans for robot-assisted surgeries
    • 3.2.1.2 Rise in the number of surgical procedures
    • 3.2.1.3 High adoption of surgical robots
    • 3.2.1.4 Technological advancements
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of robotic systems
    • 3.2.2.2 Lack of awareness
    • 3.2.2.3 Stringent regulatory approval
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Value chain analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Surgical robots
• 5.3 Pharmacy and hospital automation robots
• 5.4 Rehabilitation robots
• 5.5 Telemedicine robots
• 5.6 Non-invasive radiosurgery robots

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Laparoscopic
• 6.3 Orthopedic
• 6.4 Neurology
• 6.5 Cardiology
• 6.6 Pharmacy applications
• 6.7 Physical rehabilitation
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers (ASCs)
• 7.4 Rehabilitation centers
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 ACCURAY
• 9.2 Aethon
• 9.3 ARxIUM
• 9.4 Capsa Healthcare
• 9.5 Globus Medical
• 9.6 Hocoma
• 9.7 Intuitive Surgical
• 9.8 Johnson & Johnson
• 9.9 Medtronic
• 9.10 Omnicell
• 9.11 Reinshaw
• 9.12 Smith & Nephew
• 9.13 Stryker Corporation
• 9.14 THINK Surgical
• 9.15 Zimmer Biomet